There is one clinical trial.
The ECLA PHRI COLCOVID Trial is a simple, pragmatic randomized open controlled trial to test the effects of colchicine on moderate/high-risk hospitalized COVID-19 patients with the aim of reducing mortality.
Description: Number of participants who die
Measure: All-cause mortality Time: During hospitalization or until death, whichever comes first, assessed up to 30 daysDescription: Number of participants who require intubation for mechanical ventilation or die
Measure: Composite outcome:composite of intubation for mechanical ventilation or death. Time: During hospitalization or until death, whichever comes first, assessed up to 30 days